The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Anaphylaxis and Anesthesia: Controversies and New Insights
Open accessAbstract
PERIOPERATIVE anaphylaxis may be a life-threatening clinical condition and is typically a result of drugs or substances used for anesthesia or surgery. After anaphylaxis, allergologic assessment is essential to identify the offending agent and prevent recurrences, because no preemptive therapeutic strategies exist. This review seeks to (1) identify the clinical diagnostic pathway necessary to distinguish anaphylaxis from confounding clinical diagnoses, (2) discuss the more common allergens that cause anaphylaxis during anesthesia, (3) discuss a rational approach to the identification of the offending allergen through blood and skin testing that allows for the safe future clinical management of patients experiencing perioperative anaphylaxis, and (4) discuss new therapeutic perspectives for the management of patients whose hemodynamic collapse is unresponsive to catecholamines, the initial recommended pharmacologic intervention.Anaphylaxis occurring during the perioperative period is a clinical syndrome involving multiple organ systems. The clinical manifestations are the consequences of the immediate as well as ongoing release of preformed mediators from mast cells and basophils. Careful consideration must therefore also be given to the monitoring of the patient after the management of anaphylaxis.1,2In the early 2000s, the European Academy of Allergology and Clinical Immunology proposed to define this acute nosologic entity as “a severe, life-threatening, generalized or systemic hypersensitivity reaction,”3primarily mediated by type E immunoglobulins (IgEs). More recently, this clinical entity was defined by the second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium as follows: “Anaphylaxis is a serious allergic reaction that is rapid in onset and may cause death.”4The European Academy of Allergology and Clinical Immunology committee recommended that the term anaphylactoid , introduced for non–IgE-mediated anaphylactic reactions, should no longer be used,3but this proposal has not been universally accepted.4Classically, IgE isotype antibodies are produced on an initial exposure to an allergen in susceptible individuals and bind to high-affinity FCϵRI receptors located in the plasma membrane of tissue mast cells and blood basophils, whereas lymphocytes, eosinophils, and platelets bind IgE antibodies via low-affinity FCϵRII receptors. This initial phase of sensitization is clinically silent. On reexposure, the multimeric allergen cross-links two specific IgE receptors, creating a bridge between two IgEs. The two IgE receptors aggregate and induce a signal transduction cascade releasing systemically preformed biochemical mediators, including histamine, neutral proteases (tryptase, chymase), and proteoglycans (heparin) from intracellular granules in cells within tissues and blood. Some of these mediators, such as histamine, lead to increased nitric oxide production.5Newly formed proinflammatory phospholipid-derived mediators, including prostaglandin D2, leukotrienes, thromboxane A2, and platelet-activating factor, are released soon after. Thereafter, mast cells release numerous chemokines and cytokines that initiate recruitment and activation of additional inflammatory cells.One key issue of anaphylaxis is that a very small amount of allergen is sufficient for the cells to react. The involved target organs commonly include the skin, mucous membranes, cardiovascular and respiratory systems, and the gastrointestinal tract. The corresponding clinical signs are erythema, edema, pruritus, arterial hypotension, tachycardia, and bronchial and gastrointestinal smooth muscle constriction, described by the Ring and Messmer clinical severity scale, which was adapted to describe perioperative immediate reactions (table 1).6Although this scale does not take into account the pathophysiologic mechanisms, it is appropriate for grading the clinical severity and guiding the clinical care of immediate reactions.1,7In vivo and in vitro procedures can be used to differentiate between allergic (where an immune mechanism can be demonstrated, i.e. , an anaphylactic mechanism) and nonallergic (also previously called anaphylactoid , where an immune mechanism is ruled out) hypersensitivity reactions.The overall incidence of perioperative anaphylaxis is estimated at 1 in 10,000–20,000 anesthetic procedures, whereas it is estimated at 1 in 6,500 administrations of neuromuscular blocking agents (NMBAs).8Its exact incidence remains underestimated as reactions are underreported.Anaphylaxis is one of the rare clinical events specifically related to anesthesia leading to perioperative morbidity and mortality. Morbidity remains unknown. In France, 3% of the deaths that are partially or totally anesthesia related involve anaphylaxis,9whereas 10% of perioperative immediate hypersensitivity reactions reported to the United Kingdom Medicines Control Agency are fatal.2Nevertheless, this latter datu
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sampson, H. A., Muñoz-Furlong, A., Campbell, R. L., Adkinson, N. F., Bock, S. A., Branum, A., Brown, S. G. A., Camargo, C. A., Cydulka, R., Galli, S. J., et al. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.12.1303 · Cited by 2,313
Johansson, S. G. O., Hourihane, J. O., Bousquet, J., Bruijnzeel-Koomen, C., Dreborg, S., Haahtela, T., Kowalski, M. L., Mygind, N., Ring, J., van Cauwenberge, P., et al. (2001) · Allergy · doi:10.1034/j.1398-9995.2001.t01-1-00001.x · Cited by 1,723
INCIDENCE AND SEVERITY OF ANAPHYLACTOID REACTIONS TO COLLOID VOLUME SUBSTITUTES
Ring, J., & Messmer, K. (1977) · The Lancet · doi:10.1016/s0140-6736(77)91953-5 · Cited by 1,299
The diagnosis and management of anaphylaxis: An updated practice parameter
LIEBERMAN, P., KEMP, S., OPPENHEIMER, J., LANG, D., BERNSTEIN, I., NICKLAS, R., ANDERSON, J., BERNSTEIN, D., BERNSTEIN, J., & FINK, J. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.01.010 · Cited by 667
Kounis syndrome (allergic angina and allergic myocardial infarction): A natural paradigm?
Kounis, N. G. (2006) · International Journal of Cardiology · doi:10.1016/j.ijcard.2005.08.007 · Cited by 529
Party, M. O. T. W., Harper, N. J. N., Dixon, T., Dugué, P., Edgar, D. M., Fay, A., Gooi, H. C., Herriot, R., Hopkins, P., Hunter, J. M., et al. (2009) · Anaesthesia · doi:10.1111/j.1365-2044.2008.05733.x · Cited by 399
Anaphylaxis During the Perioperative Period
Hepner, D. L., & Castells, M. C. (2003) · Anesthesia & Analgesia · doi:10.1213/01.ane.0000082993.84883.7d · Cited by 375
Kroigaard, M., Garvey, L. H., Gillberg, L., Johansson, S. G. O., Mosbech, H., Florvaag, E., Harboe, T., Eriksson, L. I., Dahlgren, G., Seeman‐Lodding, H., et al. (2007) · Acta Anaesthesiologica Scandinavica · doi:10.1111/j.1399-6576.2007.01313.x · Cited by 268
BSACI guidelines for the management of drug allergy
Mirakian, R., Ewan, P. W., Durham, S. R., Youlten, L. J. F., Dugué, P., Friedmann, P. S., English, J. S., Huber, P. A. J., & Nasser, S. M. (2009) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2008.03155.x · Cited by 240
Anaphylaxis during Anesthesia in Norway: A 6-Year Single-center Follow-up Study
Harboe, T., Guttormsen, A. B., Irgens, A., Dybendal, T., & Florvaag, E. (2005) · Anesthesiology · doi:10.1097/00000542-200505000-00006 · Cited by 212
Metadata
- Authors
- Dewachter, P., Mouton-Faivre, C., Emala, C. W., & Riou, B.
- Venue
- Anesthesiology
- Published
- 2009-11-01
- Volume
- 111
- Issue
- 5
- Pages
- 1141-1150
- ISSN
- 0003-3022 (ISSN-L)
- OpenAlex
- W1975094261
- Cited by
- 299
- References
- 22
- FWCI
- 14.94
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Anaphylaxis and Anesthesia: Controversies and New Insights. https://app.cochat.ai/papers/10.1097/aln.0b013e3181bbd443
- The paper
- Dewachter, P., Mouton-Faivre, C., Emala, C. W., & Riou, B. (2009). Anaphylaxis and Anesthesia: Controversies and New Insights. Anesthesiology. https://doi.org/10.1097/aln.0b013e3181bbd443
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.